Search Ontology:
ChEBI
efavirenz
- Term ID
- CHEBI:119486
- Synonyms
-
- (-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE
- (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
- (S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
- (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
- 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
- Efavirenz
- Definition
- 1,4-Dihydro-2H-3,1-benzoxazin-2-one substituted at the 4 position by cyclopropylethynyl and trifluoromethyl groups (S configuration) and at the 6 position by chlorine. A non-nucleoside reverse transcriptase inhibitor with activity against HIV, it is used with other antiretrovirals for combination therapy of HIV infection.
- References
-
- Beilstein:7387333
- CAS:154598-52-4
- DrugBank:DB00625
- Drug_Central:989
- HMDB:HMDB0014763
- KEGG:C08088
- KEGG:D00896
- LINCS:LSM-5526
- PDBeChem:EFZ
- PMID:10576692
- PMID:10673109
- PMID:25017682
- Patent:EP582455
- Patent:US5519021
- Reaxys:7387333
- Wikipedia:Efavirenz
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from efavirenz
Phenotype where environments contain efavirenz
Phenotype modified by environments containing efavirenz
Human Disease Model